Policy & Regulation
L’Oréal SA Announces Recall of Effaclar Duo in the U.S.
L’Oréal Recalls Effaclar Duo in the U.S. Due to Benzene Concerns
L’Oréal Recalls Effaclar Duo after recent testing found high levels of benzene in acne treatments containing benzoyl peroxide (BPO). This voluntary recall follows a report by independent lab Valisure, which discovered the presence of benzene in several acne treatment products, including L’Oréal’s Effaclar Duo. Benzene is a known carcinogen, and its presence in skincare products raised significant concerns for consumer safety.
Why Did L’Oréal Recall Effaclar Duo?
L’Oréal took immediate action by issuing a recall of its La Roche-Posay Effaclar Duo acne treatment in response to the findings. Benzoyl peroxide, an active ingredient in many acne products, can break down into benzene under certain conditions, such as high temperatures or UV exposure. These conditions could lead to high benzene levels, which pose health risks, especially when inhaled. In collaboration with the FDA, L’Oréal decided to remove the affected product from U.S. retail shelves to prioritize consumer safety.
Additionally, this recall helps facilitate a smooth transition to a new and improved Effaclar Duo formula. The upgraded version has been in development since 2024 and is expected to be available to consumers soon.
What Products Are Affected by the Recall?
L’Oréal recalls all lots of its La Roche-Posay Effaclar Duo Acne Spot Treatment in the U.S. These specific products are no longer available for purchase on the La Roche-Posay website. However, other La Roche-Posay items, such as the Effaclar Duo cleanser, are not part of the recall and remain available for sale.
The Role of Benzene in the Recall
The decision to recall L’Oréal’s Effaclar Duo was prompted by the discovery of benzene, a toxic substance, in the acne treatments. Valisure’s lab results revealed that many acne treatments with benzoyl peroxide contain benzene levels far exceeding FDA’s safety limits. Valisure’s findings led to a petition urging the FDA to recall these products from the market to protect consumers.
In conclusion, L’Oréal Recalls Effaclar Duo to safeguard its customers and transition to a safer, more effective formula. The company is committed to ensuring the highest safety standards for its products.
**Explore more news **on this website to stay updated on product recalls and consumer safety.